During the past decade, Russian Scientific Center of Roentgenoradiology conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Russian Scientific Center of Roentgenoradiology" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored and "Kidney Cancer Research Bureau" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Russian Scientific Center of Roentgenoradiology" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Russian Scientific Center of Roentgenoradiology" are "Metastatic Prostate Cancer" (2 trials), "UC (Urothelial Cancer)" (2 trials), "Urothelial Carcinoma" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Metastatic Castrate Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Russian Scientific Center of Roentgenoradiology" in a lesser frequency.

Most popular intervention types in "Russian Scientific Center of Roentgenoradiology" are "Drug" (13 trials), "Other" (3 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Pembrolizumab" (4 trials), "Atezolizumab" (3 trials), "Epacadostat" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Russian Scientific Center of Roentgenoradiology" are 8 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Russian Scientific Center of Roentgenoradiology". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Russian Scientific Center of Roentgenoradiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Russian Scientific Center of Roentgenoradiology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".